FDA NDC Directory · JSON-LD · Markdown

Mavyret

NDC 0074-2600 · HUMAN PRESCRIPTION DRUG · PELLET

Generic nameGlecaprevir and Pibrentasvir
Labeler / ManufacturerAbbVie Inc.
Marketing categoryNew Drug Application (innovator) · App NDA215110
Dosage form / routePELLET · ORAL
Active ingredientsGLECAPREVIR (50 mg/1)
PIBRENTASVIR (20 mg/1)
Marketing started20210610
Package count1

External sources

Source: openFDA. Public-domain (CC0).